{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:02:00Z","timestamp":1761512520694},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":6633,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1990,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The long\u2010term follow\u2010up (\u00b1Mg4 years) of clinical, hormonal and radiological aspects in 22\u2018cured\u2019prolactinoma patients after adenomectomy was studied. Dynamic secretion of PRL and TSH was also evaluated, in order to identify the persistence of any underlying abnormality of hypothalamic pituitary control and to predict relapses. A relapse into hyperprolactinaemia was shown in 36% of patients 5\u201090 months (mean 46) after surgery. This was accompanied by reappearance of clinical symptoms but not by the radiological demonstration of the adenoma in any patients. A significant PRL rise after domperidone, a dopaminergic antagonist drug, was shown in cured patients after surgery (mean\u00b1SEM peak, 2977\u00b1645 mU\/1) but this was markedly lower than that observed in control subjects (5732\u00b1440 mU\/1). In fact, normal PRL increments were shown in only 6\/16 (37%) patients. TSH hyper\u2010responsiveness to domperidone normalized in only 46% of patients. Similar PRL responses to those obtained with domperidone were shown when a TRH test was given. A relapse into hyperprolactinaemia was observed in six of ten (60%) non\u2010responders to domperidone and in four of seven (57%) non\u2010responders to TRH, whereas six normal responders to domperidone and TRH had not relapsed at that time. Plasma PRL levels during pregnancy showed increments lower than those observed in normal pregnant women only in domperidone and TRH non\u2010responder patients. These results indicate that a relapse into hyperprolactinaemia and a blunted PRL rise during pregnancy were present only in patients with persistently reduced PRL response to dynamic tests.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1990.tb00901.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:06:14Z","timestamp":1205755574000},"page":"583-592","source":"Crossref","is-referenced-by-count":30,"title":["LONG\u2010TERM FOLLOW\u2010UP OF\u2018CURED\u2019PROLACTINOMA PATIENTS AFTER SUCCESSFUL ADENOMECTOMY"],"prefix":"10.1111","volume":"32","author":[{"given":"ENRICA","family":"CICCARELLI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EZIO","family":"GHIGO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CATALDO","family":"MIOLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIOVANNI","family":"GANDINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EUGENIO E.","family":"MULLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCO","family":"CAMANNI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(86)90052-1"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(82)90159-7"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-3-650"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000122965"},{"key":"e_1_2_1_6_1","first-page":"205","volume-title":"Microprolactinoma: A Clinical Problem","author":"Camanni F.","year":"1982"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-6-1270"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91841-5"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-105-3-636"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-2-263"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109022"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350635"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb00210.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-46-3-459"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90553-6"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-5-855"},{"key":"e_1_2_1_17_1","first-page":"145","article-title":"Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia","volume":"95","author":"Massara F.","year":"1980","journal-title":"Acta Endocrinological"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1983.tb03191.x"},{"key":"e_1_2_1_19_1","first-page":"333","article-title":"Influences of pregnancies on prolactinomas","volume":"100","author":"Rjosk H. K.","year":"1982","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.252.7.921"},{"key":"e_1_2_1_21_1","first-page":"1269","article-title":"Decline of tuberoinfundibular dopaminergic function resulting from chronic hyperprolactinemia in rats","volume":"115","author":"Sarkar D. K.","year":"1984","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00608.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6508.1547"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-6-1296"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308043090505"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6508.1550"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-3-302"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-5-968"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-105-5-1152"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-37-6-855"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1990.tb00901.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1990.tb00901.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T20:30:08Z","timestamp":1698006608000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1990.tb00901.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["10.1111\/j.1365-2265.1990.tb00901.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb00901.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}